QuidelOrtho
QDEL
#4767
Rank
NZ$3.26 B
Marketcap
NZ$48.05
Share price
-0.22%
Change (1 day)
-24.83%
Change (1 year)
Quidel is an American manufacturer of diagnostics testings that can be used to diagnose infectious diseases as well as cardiovascular and metabolic diseases.

EPS for QuidelOrtho (QDEL)

EPS in 2025 (TTM): NZ-$29.16

According to QuidelOrtho's latest financial reports the company's current EPS (TTM) is NZ-$29.46. In 2024 the company made an earnings per share (EPS) of NZ-$52.41 a decrease over its 2023 EPS that were of NZ-$0.28.

EPS history for QuidelOrtho from 2012 to 2025

Annual EPS

Year EPS Change
2025 (TTM)NZ-$29.16-44.36%
2024NZ-$52.4118825%
2023NZ-$0.28-101.27%
2022NZ$21.78-25.12%
2021NZ$29.08-12.64%
2020NZ$33.29980.34%
2019NZ$3.08-10.1%
2018NZ$3.43-960.87%
2017NZ-$0.40
2015NZ-$0.29-15%
2014NZ-$0.35-190.91%
2013NZ$0.3846.67%
2012NZ$0.26

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Meridian Bioscience
VIVO
NZ$1.68-105.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Becton Dickinson
BDX
NZ$9.64-132.73%๐Ÿ‡บ๐Ÿ‡ธ USA
Thermo Fisher Scientific
TMO
NZ$30.02-201.88%๐Ÿ‡บ๐Ÿ‡ธ USA
OraSure Technologies
OSUR
NZ-$1.38-95.30%๐Ÿ‡บ๐Ÿ‡ธ USA
Danaher
DHR
NZ$8.45-128.67%๐Ÿ‡บ๐Ÿ‡ธ USA
PerkinElmer
PKI
NZ$13.33-145.24%๐Ÿ‡บ๐Ÿ‡ธ USA